Clinical Trial Update: Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated panobinostat in combination with ICE chemotherapy for relapsed Hodgkin lymphoma, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• ICE
• Panobinostat (Panobinostat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-01-06